申请人:SARcode Bioscience Inc.
公开号:US20140051675A1
公开(公告)日:2014-02-20
The present invention provides compounds having formula (I):
and pharmaceutically acceptable derivatives thereof, wherein R
1
-R
4
, n, p, A, B, D, E, L and AR
1
are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).
本发明提供具有式(I)的化合物及其药学上可接受的衍生物,其中R1-R4、n、p、A、B、D、E、L和AR1的描述如本文中一般和各类和子类中所述,并且还提供了其药物组成物以及使用它们治疗由CD11/CD18细胞黏附分子(例如LFA-1)介导的疾病的方法。